GSK News and Press, GlaxoSmithKline PLC From 05/11/24

2024-05-11 12:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-08 12:01:57 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investible candidates that may b...

2024-05-08 10:46:32 ET More on Pfizer Pfizer: A 6% Yield And At 10-Year Lows Pfizer Stock: Not A Value Trap, Here's Why Pfizer: Solid Earnings, But We're Not Out Of The Woods Yet Boy given Pfizer experimental Duchenne muscular dystrophy therapy dies P...

2024-05-07 14:08:58 ET More on GSK GSK plc (GSK) Q1 2024 Earnings Call Transcript GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript) GSK Non-GAAP EPS of 43.10p, revenue o...

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis GSK to participate in Series C Extension with equity investment Series C financing round extended overall by CHF 12.3 million to CHF 44.9 million ...

2024-05-04 15:30:00 ET Read the full article on Seeking Alpha For further details see: Pharma R&D productivity seen improving for the first time in years - Deloitte

2024-05-04 00:00:06 ET GSK plc (GSK) Q1 2024 Earnings Conference Call May 01, 2024 03:00 AM ET Company Participants Nick Stone - Head of Investor Relations Emma Walmsley - Chief Executive Officer Luke Miels - Chief Commercial Officer Deborah Waterhouse - Chie...

2024-05-03 12:47:06 ET Summary Vir Biotechnology, Inc. reported its first-quarter earnings after the bell on Thursday, giving its shareholders some positive tidbits. The company continues to have a cash balance higher than the stock's market capitalization and has some potential u...

2024-05-02 13:48:51 ET More on Moderna Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Moderna Investors Should Beware Patent-Dispute Fallout Moderna tops forecasts in Q1 despite COVID-related...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...